title: A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder.
abstract: Several antiepileptic drugs (AEDs) have documented efficacy in the manic phase of bipolar disorder. To investigate the efficacy, tolerability, and safety of the new AED, gabapentin, in mania, we treated nine consecutive outpatients with bipolar I or II disorder by DSM-IV criteria who were experiencing hypomanic, manic, or mixed states inadequately responsive to standard mood stabilizers with open-label, adjunctive gabapentin. Response of manic symptoms was assessed monthly as none, minimal, moderate, or marked. Of the nine patients, seven displayed a moderate or marked reduction in manic symptoms by 1 month after addition of gabapentin, and an additional patient displayed moderate improvement after 3 months. Of these eight patients, six displayed continued antimanic responses for follow-up periods ranging from 1 to 7 months. Side effects were most commonly neurological, mild, and transient. Adjunctive gabapentin may have antimanic and mood-stabilizing effects in some patients with bipolar disorder and is generally well tolerated. Controlled studies of gabapentin in bipolar disorder appear to be warranted.
authors.affiliation: Department of Psychiatry, University of Cincinnati College of Medicine, Ohio 45267-0559, USA.
authors.forename: S L
authors.initials: SL
authors.lastname: McElroy
authors.forename: C A
authors.initials: CA
authors.lastname: Soutullo
authors.forename: P E
authors.initials: PE
authors.lastname: Keck
authors.forename: G F
authors.initials: GF
authors.lastname: Kmetz
mesh_terms: D000085:Acetates / Q000494:pharmacology / Q000627:therapeutic use*; D000277:Adjuvants, Pharmaceutic / Q000008:administration & dosage*; D000328:Adult; D000339:Affect / Q000187:drug effects; D000588:Amines; D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D003509:Cyclohexanecarboxylic Acids; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000277:Adjuvants, Pharmaceutic; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin